BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 19701758)

  • 1. Evaluation of genes identified by microarray analysis in favorable neuroblastoma.
    Kamei N; Hiyama K; Yamaoka H; Kamimatsuse A; Onitake Y; Sueda T; Hiyama E
    Pediatr Surg Int; 2009 Nov; 25(11):931-7. PubMed ID: 19701758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression profiling of favorable and unfavorable neuroblastomas.
    Hiyama E; Hiyama K; Yamaoka H; Sueda T; Reynolds CP; Yokoyama T
    Pediatr Surg Int; 2004 Jan; 20(1):33-8. PubMed ID: 14691637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High expression of the novel endothelin-converting enzyme genes, Nbla03145/ECEL1alpha and beta, is associated with favorable prognosis in human neuroblastomas.
    Kawamoto T; Ohira M; Hamano S; Hori T; Nakagawara A
    Int J Oncol; 2003 Apr; 22(4):815-22. PubMed ID: 12632073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential gene expression profiles between neuroblastomas with high telomerase activity and low telomerase activity.
    Hiyama E; Hiyama K; Nishiyama M; Reynolds CP; Shay JW; Yokoyama T
    J Pediatr Surg; 2003 Dec; 38(12):1730-4. PubMed ID: 14666454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel risk stratification of patients with neuroblastoma by genomic signature, which is independent of molecular signature.
    Tomioka N; Oba S; Ohira M; Misra A; Fridlyand J; Ishii S; Nakamura Y; Isogai E; Hirata T; Yoshida Y; Todo S; Kaneko Y; Albertson DG; Pinkel D; Feuerstein BG; Nakagawara A
    Oncogene; 2008 Jan; 27(4):441-9. PubMed ID: 17637744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential expression of neuronal genes defines subtypes of disseminated neuroblastoma with favorable and unfavorable outcome.
    Fischer M; Oberthuer A; Brors B; Kahlert Y; Skowron M; Voth H; Warnat P; Ernestus K; Hero B; Berthold F
    Clin Cancer Res; 2006 Sep; 12(17):5118-28. PubMed ID: 16951229
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene expression profiling and identification of novel prognostic marker genes in neuroblastoma.
    Takita J; Ishii M; Tsutsumi S; Tanaka Y; Kato K; Toyoda Y; Hanada R; Yamamoto K; Hayashi Y; Aburatani H
    Genes Chromosomes Cancer; 2004 Jun; 40(2):120-32. PubMed ID: 15101045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single nucleotide polymorphism array analysis to predict clinical outcome in neuroblastoma patients.
    Hiyama E; Yamaoka H; Kamimatsuse A; Onitake Y; Hiyama K; Nishiyama M; Sueda T
    J Pediatr Surg; 2006 Dec; 41(12):2032-6. PubMed ID: 17161199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The high level of hCDC10 gene expression in neuroblastoma may be associated with favorable characteristics of the tumor.
    Nagata T; Takahashi Y; Asai S; Ishii Y; Mugishima H; Suzuki T; Chin M; Harada K; Koshinaga S; Ishikawa K
    J Surg Res; 2000 Aug; 92(2):267-75. PubMed ID: 10896833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A three-gene expression signature model for risk stratification of patients with neuroblastoma.
    Garcia I; Mayol G; Ríos J; Domenech G; Cheung NK; Oberthuer A; Fischer M; Maris JM; Brodeur GM; Hero B; Rodríguez E; Suñol M; Galvan P; de Torres C; Mora J; Lavarino C
    Clin Cancer Res; 2012 Apr; 18(7):2012-23. PubMed ID: 22328561
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of subsets of neuroblastomas by combined histopathologic and N-myc analysis.
    Shimada H; Stram DO; Chatten J; Joshi VV; Hachitanda Y; Brodeur GM; Lukens JN; Matthay KK; Seeger RC
    J Natl Cancer Inst; 1995 Oct; 87(19):1470-6. PubMed ID: 7674334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression and mutational analysis of the DCC, DPC4, and MADR2/JV18-1 genes in neuroblastoma.
    Kong XT; Choi SH; Inoue A; Xu F; Chen T; Takita J; Yokota J; Bessho F; Yanagisawa M; Hanada R; Yamamoto K; Hayashi Y
    Cancer Res; 1997 Sep; 57(17):3772-8. PubMed ID: 9288786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Invariant natural killer T infiltration in neuroblastoma with favorable outcome.
    Hishiki T; Mise N; Harada K; Ihara F; Takami M; Saito T; Terui K; Nakata M; Komatsu S; Yoshida H; Motohashi S
    Pediatr Surg Int; 2018 Feb; 34(2):195-201. PubMed ID: 29018959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular profiling of high-risk neuroblastoma by cDNA array.
    Sardi I; Tintori V; Marchi C; Veltroni M; Lippi A; Tucci F; Tamburini A; Bernini G; Faulkner L
    Int J Mol Med; 2002 May; 9(5):541-5. PubMed ID: 11956663
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Positional gene expression analysis identifies 12q overexpression and amplification in a subset of neuroblastomas.
    Su WT; Alaminos M; Mora J; Cheung NK; La Quaglia MP; Gerald WL
    Cancer Genet Cytogenet; 2004 Oct; 154(2):131-7. PubMed ID: 15474148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High Skp2 expression characterizes high-risk neuroblastomas independent of MYCN status.
    Westermann F; Henrich KO; Wei JS; Lutz W; Fischer M; König R; Wiedemeyer R; Ehemann V; Brors B; Ernestus K; Leuschner I; Benner A; Khan J; Schwab M
    Clin Cancer Res; 2007 Aug; 13(16):4695-703. PubMed ID: 17652624
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Array-based gene expression, CGH and tissue data defines a 12q24 gain in neuroblastic tumors with prognostic implication.
    Wolf M; Korja M; Karhu R; Edgren H; Kilpinen S; Ojala K; Mousses S; Kallioniemi A; Haapasalo H
    BMC Cancer; 2010 May; 10():181. PubMed ID: 20444257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroblastoma tumors with favorable and unfavorable outcomes: Significant differences in mRNA expression of genes mapped at 1p36.2.
    Fransson S; Martinsson T; Ejeskär K
    Genes Chromosomes Cancer; 2007 Jan; 46(1):45-52. PubMed ID: 17044048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genome-wide methylation profiling identifies novel methylated genes in neuroblastoma tumors.
    Olsson M; Beck S; Kogner P; Martinsson T; Carén H
    Epigenetics; 2016; 11(1):74-84. PubMed ID: 26786290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distinct transcriptional MYCN/c-MYC activities are associated with spontaneous regression or malignant progression in neuroblastomas.
    Westermann F; Muth D; Benner A; Bauer T; Henrich KO; Oberthuer A; Brors B; Beissbarth T; Vandesompele J; Pattyn F; Hero B; König R; Fischer M; Schwab M
    Genome Biol; 2008 Oct; 9(10):R150. PubMed ID: 18851746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.